17 71

Cited 0 times in

A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)

Authors
Park, YH | Kim, TY | Kim, GM | Jung, KH | Kang, SY  | Park, IH | Kim, JH | Lee, KE | Ahn, HK | Lee, MH | Kim, HJ | Kim, HJ | Lee, JI | Koh, SJ | Kim, JY | Lee, KH | Sohn, J | Kim, SB | Im, YH | Im, SA
Citation
Journal of clinical oncology, 37(15_suppl). : 1007-1007, 2019
Journal Title
Journal of clinical oncology
ISSN
0732-183X1527-7755
DOI
10.1200/JCO.2019.37.15_suppl.1007
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Ajou Authors
강, 석윤
Files in This Item:
10.1200_JCO.2019.37.15_suppl.1007.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse